Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,217,666
+$31,884 QoQ
Shares Held
8,732
-2.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.13%
of 13F equity value
Holder Rank
#2,264
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FAIRFIELD, BUSH & CO. holds $16,010,185 across 9 Drug Manufacturers - General names. JNJ ranks #4 (13.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,869 | $3,441,164 | |
| 2 | NVS |
Novartis AG
|
19,239 | $3,015,136 | |
| 3 | MRK |
Merck & Co., Inc.
|
20,842 | $2,678,197 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
8,732 | $2,217,666 | |
| 5 | ABBV |
AbbVie Inc.
|
7,031 | $1,769,280 | |
| 6 | AMGN |
Amgen Inc
|
2,933 | $1,062,097 | |
| 7 | NVO |
Novo Nordisk A S
|
18,073 | $866,419 | |
| 8 | PFE |
Pfizer Inc
|
29,294 | $705,399 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,217,666 | 8,732 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,185,782 | 8,942 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,961,265 | 9,477 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,866,623 | 10,067 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,595,015 | 10,442 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $1,756,743 | 10,593 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,565,511 | 10,825 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,906,635 | 11,765 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,895,402 | 12,968 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $2,259,744 | 14,285 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,250,786 | 14,360 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,402,755 | 15,427 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $6,521,819 | 39,402 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $5,974,165 | 38,543 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,595,518 | 14,693 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,500,388 | 15,306 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $2,917,199 | 16,434 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $3,234,093 | 18,248 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $3,271,371 | 19,123 | Shares | Sole | 2022-05-12 | |
| 2021-09-30 | $3,714,500 | 23,000 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $7,026,819 | 42,654 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $7,289,579 | 44,354 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $7,000,577 | 44,482 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $6,786,992 | 45,587 | Shares | Sole | 2020-11-18 | |
| 2020-06-30 | $6,271,394 | 44,595 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $5,371,609 | 40,964 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||